Our study reveals that eosinopenia and elevated LDH on admission are
potential predictors of disease severity in adults with COVID-19 and
underlying chronic airway diseases. These predictors may help clinicians
identify the severe COVID-19 patients with chronic bronchitis, COPD, and
asthma.